About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Pittsburgh | 219 Studies

Clinical Trials Prostate CancerPittsburgh

Prostate Cancer Clinical Trials in Pittsburgh

Find 219 clinical trials for prostate cancer near Pittsburgh, Pennsylvania. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Pittsburgh

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 219 trials

CompletedTrial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate CancerThis is a phase I, open-label trial to evaluate the safety and immunogenicity of INO 5150 alone or in combination with INO-9012 when delivered intramuscularly (IM) followed by…NCT02514213·Baltimore, Maryland and 9 others CompletedA Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate CancerThe purpose of this study is to evaluate the prevalence of 4 or more DNA-repair gene defects in a population of men with metastatic Prostate Cancer (PC) and to use the reported…NCT03871816·Homewood, Alabama and 337 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedGSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsThe purpose of this study is to evaluate if the combination of GSK3359609 and tremelimumab is safe and tolerable (Part 1) and provides significant survival benefit to subjects…NCT03693612·Boston, Massachusetts and 7 others

CompletedHormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells.NCT00032006·Scottsdale, Arizona and 7 others

TerminatedPRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)Open-label, multicenter, dose titration and four-arm expansion trial to evaluate the safety, tolerability, immunogenicity, and preliminary efficacy of BNT112 cancer vaccine…NCT04382898·Tucson, Arizona and 21 others

RecruitingAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free survival (rPFS) and…NCT07611110·Dothan, Alabama and 131 others

RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 580 others

TerminatedDose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsThis is a Phase 1, multicenter, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor…NCT04931823·Los Angeles, California and 7 others

CompletedHormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT00288080·Birmingham, Alabama and 253 others

Active not recruitingCapivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN DeficiencyThis study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone…NCT04493853·Tucson, Arizona and 322 others

RecruitingSafety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsA Phase 1 Open-Label, First-in-human, Dose Escalation and Expansion Study to Determine the Safety, Tolerability, Dosimetry, Pharmacokinetics, and Preliminary Efficacy of…NCT05283330·Chicago, Illinois and 7 others

CompletedDiet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceRATIONALE: Eating a diet high in vegetables may slow down disease progression in patients with prostate cancer.NCT01238172·Fairbanks, Alaska and 179 others

Active not recruitingA Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)This Phase II study aims to evaluate the efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg QD doses + lutetium (177Lu)…NCT07047118·Duarte, California and 43 others

Active not recruitingSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsThe intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA by assessment of radiographic…NCT06120491·Chandler, Arizona and 321 others

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

TerminatedA Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)The study will evaluate the safety, pharmacokinetics and pharmacodynamics of increasing doses of a vaccine-based immunotherapy regimen for patients with prostate cancer.NCT02616185·Tucson, Arizona and 18 others

CompletedABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the BodyA clinical trial examining the safety and effectiveness of ABX-EGF when given to patients with prostate cancer with or without tumor in other parts of the body.NCT00061126·Birmingham, Alabama and 8 others

CompletedChemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaVA Cooperative Study #553 is designed to prospectively evaluate the efficacy of early adjuvant chemotherapy using docetaxel and prednisone added to the standard of care for…NCT00132301·Birmingham, Alabama and 33 others

CompletedPSA Vaccine Therapy in Treating Patients With Advanced Prostate CancerRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00003871·Indianapolis, Indiana and 9 others

CompletedStudy of Immunotherapy to Treat Advanced Prostate CancerThe purpose of the study is to determine if advanced prostate cancer patients that are treated with radiotherapy (RT) plus ipilimumab live longer that those treated with RT aloneNCT00861614·Mobile, Alabama and 157 others

PreviousPage 3 of 11Next

Other Conditions in Pittsburgh

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma